Regencell Bioscience Holdings (Regencell Bioscience Holdings) Net Margin %

: 0.00% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Regencell Bioscience Holdings's Net Income for the six months ended in Jun. 2023 was $-2.64 Mil. Regencell Bioscience Holdings's Revenue for the six months ended in Jun. 2023 was $0.00 Mil. Therefore, Regencell Bioscience Holdings's net margin for the quarter that ended in Jun. 2023 was 0.00%.

The historical rank and industry rank for Regencell Bioscience Holdings's Net Margin % or its related term are showing as below:

RGC's Net Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 3.765
* Ranked among companies with meaningful Net Margin % only.

Regencell Bioscience Holdings Net Margin % Historical Data

The historical data trend for Regencell Bioscience Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Net Margin %

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Net Margin %					-	-	-	-	-

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Net Margin % falls into.

Regencell Bioscience Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Regencell Bioscience Holdings's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-5.871	/	0
	=	%

Regencell Bioscience Holdings's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-2.644	/	0
	=	%

Regencell Bioscience Holdings (NAS:RGC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Regencell Bioscience Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.